Endava (DAVA)
(Delayed Data from NYSE)
$25.32 USD
+0.03 (0.12%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $25.31 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$25.32 USD
+0.03 (0.12%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $25.31 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth C Momentum A VGM
Zacks News
BlackBerry (BB) Reports Narrower-Than-Expected Loss in Q1
by Zacks Equity Research
BlackBerry's (BB) first-quarter fiscal 2022 results reflect significant progress of the auto business despite headwinds related to global chip shortage.
Why Endava PLC Sponsored ADR (DAVA) Might be Well Poised for a Surge
by Zacks Equity Research
Endava PLC Sponsored ADR (DAVA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Why Endava (DAVA) Could Be an Impressive Growth Stock
by Zacks Equity Research
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Endava (DAVA).
Endava PLC Sponsored ADR (DAVA) Moves 3.9% Higher: Will This Strength Last?
by Zacks Equity Research
Endava PLC Sponsored ADR (DAVA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Endava PLC Sponsored ADR (DAVA) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Endava PLC Sponsored ADR (DAVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Endava PLC Sponsored ADR (DAVA) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Endava PLC Sponsored ADR (DAVA) delivered earnings and revenue surprises of 8.57% and 1.91%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Endava PLC Sponsored ADR (DAVA) Q2 Earnings Expected to Decline
by Zacks Equity Research
Endava PLC Sponsored ADR (DAVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Endava PLC Sponsored ADR (DAVA) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Endava PLC Sponsored ADR (DAVA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is Endava (DAVA) a Great Growth Stock?
by Zacks Equity Research
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Endava (DAVA).
Can Endava (DAVA) Stock Continue to Grow Earnings?
by Zacks Equity Research
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Endava (DAVA).
Will Endava Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Endava.
Epam (EPAM) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Epam (EPAM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
The Zacks Analyst Blog Highlights: Fair Isaac, CDW, EPAM and Endava
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Fair Isaac, CDW, EPAM and Endava
Usher in 2020 With 4 Top IT Services Stocks to Reap Benefits
by Madhura Bhattacharyya
Take a sneak peek at four IT services stocks that investors can bank on for handsome returns in 2020.
New Strong Buy Stocks for November 27th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
Endava (DAVA) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Endava's (DAVA) first-quarter fiscal 2020 results gain from strong segmental strength across each of its geographical regions.
The Zacks Analyst Blog Highlights: Rio Tinto, Smith & Nephew, Endava, AstraZeneca and British American Tobacco
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Rio Tinto, Smith & Nephew, Endava, AstraZeneca and British American Tobacco
Is Britain Headed for a Soft Brexit? 5 Picks
by Swarup Gupta
Following May's fresh legislative defeat, Britain could exit the EU while retaining access to its common market.
Top Ranked Momentum Stocks to Buy for December 6th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, December 6th
Zacks.com featured highlights include: Bausch Health, Endava, DaVita, Perspecta and Athene Holding
by Zacks Equity Research
Zacks.com featured highlights include: Bausch Health, Endava, DaVita, Perspecta and Athene Holding
5 Dirt-Cheap PEG Stocks That Value Investors Love
by Zacks Equity Research
For investors looking to escape value traps, it is vital to determine where the stock is headed in the next 12 to 24 months.